Published June 19, 2020
| Version v1
Journal article
Open
The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of nucleic acid (RNA and DNA) vaccines
Description
Nucleic acid (DNA and RNA) vaccines are among the most advanced vaccines for COVID-19 under development. The Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG) has prepared a standardized template to describe the key considerations for the benefit-risk assessment of nucleic acid vaccines. This will facilitate the assessment by key stakeholders of potential safety issues and understanding of overall benefit-risk. The structured assessment provided by the template can also help improve communication and public acceptance of licensed nucleic acid vaccines.
Notes
The SPEAC Project is funded in whole by CEPI
Files
Nucleic_Acid_Vaccines_Template_20200711.pdf
Files
(253.3 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:453ea670ec7f03e60c176659d9617f8a
|
253.3 kB | Preview Download |